🇺🇸 US Stock Screener ← Switch market ★ Elite Club ⚡ HerAI

VNRX VNRX

Company Profile ↓
$0.80
-93.79% 1Y
Mkt Cap$5.03M
P/E-0.18
P/B-0.15
52W High$13.80
52W Low$0.72
Book Value$-5.45
EPS (TTM)$-4.40

Company Overview

VNRX (VNRX) is a publicly traded company listed on with a market capitalization of $5.03M. The valuation, growth and price-trend signals below summarize what matters most to investors and traders evaluating the stock.

Why Investors Should Care

Strong Return on Equity

Generates a return on equity of 68.2%, reflecting efficient use of shareholder capital.

Steady Revenue Expansion

Revenue has grown at a 63.6% CAGR over the past five years.

Recent Developments

  • Dec 2025 Revenue of $1.73M (+40.0% YoY); net profit $-23.36M.
  • Trailing 12 Months Year-on-year growth — revenue +40.0%.
  • 5-Year Trend Long-term compounding — revenue CAGR 63.6%.

Growth & Price Performance

Compounded Sales Growth

5 Years:63.64%
1 Year:40.04%

Stock Price Performance

1 Year:-93.79%
6 Months:-85.28%
3 Months:-65.88%
1 Month:-43.21%

Highlights auto-generated from reported financials and price data; not investment advice. Verify with official filings before acting.

Technical Snapshot Bearish
52-Week Range 1% of range
$0.72 $13.80
Trend Signals
  • Price vs 50-DMABelow
  • Price vs 200-DMABelow
  • RSI (14)29.48 · Oversold
Price Performance
1M-43.21%
3M-65.88%
6M-85.28%
1Y-93.79%

Auto-generated from price history and fundamentals; not investment advice.

⚙Ad space

Price Chart

Robinhood TradingView

Fundamental Growth Charts

Interactive charts for Revenue, Net Income, EBITDA, Free Cash Flow, EPS, ROE, ROCE, Gross/Net/Operating Margin and more — switch metric and period using the dropdowns above. CAGR is computed across the displayed window (quarterly CAGR is annualised). Visual growth charts make it easy to spot multi-year compounding trends at a glance — far faster than reading raw numbers in a table.

PROS

  • Strong return on equity of 68.2%.
  • Compounding revenue at 63.6% over 5 years.

CONS

  • Trading 94.2% below its 52-week high.
  • In a downtrend (50-DMA below 200-DMA).

* The pros and cons are auto-generated from financial metrics.

⚙Ad space

Valuation

Stock P/E
-0.18
Industry PE
-
Forward P/E
-
PEG Ratio
-
Book Value
$-5.45
Price to Book
-0.15
P/S
-
EV/EBITDA
-
Dividend Yield
0.00%

Growth (CAGR)

Revenue 5Y
63.64%
Profit 5Y
-
Revenue (YoY)
40.04%
Earnings (YoY)
-

Profitability & Returns

ROCE
-
ROE
68.20%
ROA
-
Profit Margin
-
Op Margin
-
Gross Margin
-
EPS (Latest Qtr)
$-0.97
EPS (TTM)
$-4.40

Balance Sheet & Liquidity

Debt/Equity
-
Quick Ratio
-
Current Ratio
0.17
Debt
$11.46M
Total Assets
$9.04M
Current Assets
$4.52M
Working Capital
$-10.17M

Ownership

Promoter Holding
8.62%
Chg in Prom Hold
-
FII / Inst Holding
20.77%
Chg in FII Hold
-

Financial Snapshot

Enterprise Value
-
Total Revenue (TTM)
$1.73M
EBITDA
$-19.80M
Free Cash Flow
$-19.77M
Operating Cash Flow
$-19.68M
Shares Outstanding
6.29M
Gross Margin
-
Payout Ratio
-
Financial Statements Quarterly Results · Profit & Loss · Balance Sheet · Cash Flows · Ratios

Quarterly Results

Figures in USD.

Metric Sep 2013Mar 2014Jun 2014Sep 2014Mar 2015Jun 2015Sep 2015Mar 2016Jun 2016Sep 2016Mar 2017Jun 2017Sep 2017Mar 2018Jun 2018Sep 2018Mar 2019Jun 2019Sep 2019Mar 2020Jun 2020Sep 2020Mar 2021Jun 2021Sep 2021Mar 2022Jun 2022Sep 2022Mar 2023Jun 2023Sep 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026
Revenue ---14.79K-------------017.10K5445.19K57525.53K24.78K25.48K114.21K39.75K32.71K149.81K216.31K165.21K171.53K395.80K474.52K-246.38K406.69K627.28K447.03K985.08K
Cost of Revenue ----------------------------------------
Gross Profit ----------------------------------------
Operating Expenses -----------------------------------5.65M6.63M5.50M5.18M6.21M
Operating Income -925.57K-1.24M-1.05M-1.76M-2.35M-2.02M-2.97M-2.49M-2.98M-3.48M-3.34M-3.44M-3.88M-4.63M-4.57M-4.45M-3.99M-4.15M-4.18M-5.87M-5.21M-4.50M-6.09M-5.90M-7.56M-7.68M-8.10M-7.99M-9.05M-9.55M-8.65M-8.38M-6.99M-5.87M--5.40M-6.22M-4.87M-4.73M-5.23M
EBITDA ------------------------------------5.07M-5.55M-4.23M-4.95M-5.87M
Interest Expense -----------------------------------96.67K448.66K873.43K1.07M575.98K
Pretax Income ------------------------------------5.48M-6.31M-5.41M-6.30M-6.70M
Tax Provision ----------------------------------------
Net Income -925.57K-2.19M816.80K-5.89M-2.01M-1.87M-2.96M-2.49M-2.95M-3.48M-3.35M-3.46M-3.89M-4.65M-4.59M-4.48M-4.20M-4.16M-4.18M-5.86M-5.04M-4.34M-6.13M-5.57M-7.18M-7.72M-7.73M-7.81M-8.87M-9.55M-8.45M-8.37M-6.99M-5.82M--5.42M-6.28M-5.38M-6.27M-6.66M
Diluted EPS --0.06-0.44--0.10-0.16-------------------------0.10-0.08-0.07--1.12-1.20-1.00--0.97
R&D Expense 524.53K870.46K791.29K1.07M1.21M1.36M1.86M1.46M1.75M1.97M1.67M1.81M2.13M2.42M2.69M2.74M2.47M2.48M2.64M3.89M3.49M3.18M3.87M2.94M3.61M3.59M3.28M4.00M4.91M5.45M4.65M4.63M3.72M3.47M-2.61M2.72M2.29M-2.85M

Profit & Loss (Annual)

Figures in USD.

Metric Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Revenue -54.97K-14.79K----17.10K13.43K-306.39K775.30K1.23M1.73M
Cost of Revenue ---------------
Gross Profit ---------------
Operating Expenses -----------30.86M36.55M28.16M22.95M
Operating Income -2.61M-4.08M-4.58M-5.95M-10.01M-12.43M-14.70M-17.90M-16.04M-21.25M--30.55M-35.77M-26.92M-21.22M
EBITDA ------------29.24M-34.04M-25.58M-19.80M
Interest Expense -----------173.09K221.62K340.36K2.49M
Pretax Income ------------30.60M-35.68M-27.26M-23.50M
Tax Provision ---------------
Net Income -2.61M-4.08M-3.71M-8.21M-9.53M-11.91M-14.77M-18.01M-16.10M-20.40M--30.27M-35.32M-26.97M-23.36M
Diluted EPS ------------11.00-10.00-6.20-4.40
R&D Expense 1.52M2.77M2.50M4.04M6.10M7.90M8.03M10.91M10.36M14.53M13.02M15.33M19.55M14.41M10.08M

Balance Sheet (Annual)

Figures in USD.

Metric Dec 2010Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Total Assets -2.25M2.22M2.07M3.43M7.71M24.73M14.62M17.49M21.29M26.15M27.49M18.30M27.95M9.40M6.90M
Current Assets ------------12.17M21.85M4.06M2.06M
Cash & Equivalents 47.48K347.89K376.42K-2.14M5.92M21.68M10.12M13.43M16.97M19.44M20.58M10.87M20.73M3.26M1.12M
Inventory ----------------
Receivables ------------72.61K242.62K110.57K317.81K
Total Liabilities -1.16M1.38M1.39M3.06M1.67M3.56M4.67M5.35M7.09M9.86M9.77M21.42M36.66M35.51M42.49M
Current Liabilities -534.36K747.77K957.27K2.71M1.12M2.03M2.29M2.33M3.86M6.24M6.52M17.39M8.94M7.79M12.23M
Long Term Debt -----20.37K432.03K1.31M1.98M2.20M2.61M2.27M2.78M3.62M3.95M7.26M
Total Debt ------------4.97M5.86M5.82M11.46M
Total Equity -1.09M833.79K680.67K368.18K6.04M21.18M9.96M12.14M14.20M16.29M17.72M-2.57M-7.80M-24.91M-34.25M
Shares Outstanding ------------2.89M4.09M4.80M6.29M

Cash Flows (Annual)

Figures in USD.

Metric Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Operating Cash Flow -1.65M-2.31M-3.08M-4.14M-8.55M-8.86M-12.19M-14.73M-12.74M-16.46M--15.28M-18.06M-25.89M-19.68M
Investing Cash Flow -34.87K-90.69K-714-302.99K-132.19K-415.09K-1.43M-301.81K-511.27K-1.65M--1.57M-1.08M-573.85K-89.56K
Financing Cash Flow 1.98M2.47M3.59M5.74M12.44M25.19M1.97M17.97M16.93M20.62M-6.94M28.98M8.66M17.09M
Capital Expenditure -34.87K-90.69K-714-302.99K-77.19K-415.09K-1.43M301.81K-511.27K-1.94M--1.57M-1.08M-573.85K-89.56K
Free Cash Flow -1.69M-2.41M-3.08M-4.44M-8.62M-9.28M-13.62M-14.43M-13.25M-18.41M--16.85M-19.15M-26.47M-19.77M
Net Change in Cash ------------9.91M9.84M-17.81M-2.68M
Share Buybacks -----------031.77K0-

Ratios (Annual)

Figures in %.

Metric Dec 2011Dec 2012Dec 2013Dec 2014Dec 2015Dec 2016Dec 2017Dec 2018Dec 2019Dec 2020Dec 2021Dec 2022Dec 2023Dec 2024Dec 2025
Gross Margin % ---------------
Operating Margin % --7,428.0%--40,258.4%-----93,840.2%-158,176.2%--9,971.1%-4,614.1%-2,182.5%-1,228.6%
Net Margin % --7,428.0%--55,553.1%-----94,168.5%-151,859.6%--9,879.1%-4,555.5%-2,186.3%-1,352.2%
ROE % -239.5%-489.7%-545.1%-2,230.9%-157.7%-56.2%-148.3%-148.3%-113.4%-125.2%-1,175.5%452.7%108.3%68.2%
ROCE % -152.5%-277.9%-411.0%-826.7%-151.8%-54.8%-119.2%-118.1%-92.0%-106.7%--3,361.0%-188.2%-1,673.4%398.2%

Shareholding Pattern

Insiders
8.62%
Institutions
20.77%
Public Float
22.73%

Analyst View

Loading analyst coverage…

Latest News

Recent headlines for VNRX

Google News Wed, 05 Aug 2026

Volition's early liquid biopsy study detected 49 of 49 cancers - Stock Titan

<a href="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPRVlNQXk5bDFSMkdaRVN4dEVwQVZjQVJYSE8wYjJRNFd0dTBJOG5MOHpLSUVGS056ZDEzNjdJdERtWUdrZkJJMFR4djRfeEZLd1hsN3E2X3RsOUtmLXV6eVU4c3gyY1V5bXplUUVycFRaYmUzWnhSYU1KMVd3Mk9RbFBoZHFTMGNEcTRzSj…

Google News Sat, 11 Jul 2026

VolitionRx (VNRX) Stock Gets Fair Value Boost As Analysts Split On Nu.Q Execution - Yahoo Finance

<a href="https://news.google.com/rss/articles/CBMinAFBVV95cUxNT20xS3pvaGdmSzBJR1FwRDNGRGdnMkV2Wkc3ZVBiYVBmZHRMcUQxMUR4MUdtRUZjR0M1dXd0QWVqdXl3RHVoRWRxbUdkRFAxbWVkbE14bHlVZ29QdG5URERzT0hmclo2RGhKVVFhUUxmTjNpaG0yMV9ydXlMSUpxeE5lWkxNeHU4R3dxdG…

Google News Wed, 25 Mar 2026

VNRX Stock Soars 34% Pre-Market — What's Driving The Rally? - Stocktwits

<a href="https://news.google.com/rss/articles/CBMitAFBVV95cUxQUkU4a1VWV2tKdm5ickU4YmtaSUN6MVZUTzRFWW5WV0wwOTVGZVZLeTN1dG5abEpNSkdKQ1dHTkpnVkNTV1hTRkZQU2xKVXg2S25GSUd0bFZSUlhENVUxM0ZUUTdmMWFFUGpmdV9FYzZuLTE5T1pZMFZEX19xZEFrOUc3TnVzeC1wNUVGSW…

Google News hu, 25 Jun 2026

VNRX Forecast — Price Target — Prediction for 2027 - TradingView

<a href="https://news.google.com/rss/articles/CBMid0FVX3lxTFB3eXB3VHFfLU1vRWYxV0hqelNCUXUtTDlhdzJ6dUxaVGxvLTRCd3Y4ckVYUVhhLWRYTnJEaENRRmZxOG5zUTFBTGotSHhDOEc5ZlRjYk5RTVJpNFpDeUZPWHprSmc5RW9EcFFtLW9XcFc5dmViYjln?oc=5" target="_blank">VNRX Fo…

Google News Mon, 08 Jun 2026

VolitionRx stock tumbles on $4.6M offering priced at discount - Investing.com

<a href="https://news.google.com/rss/articles/CBMivgFBVV95cUxPR25wdjhHT2lHT2g5XzdxazJpMUp3X29fbUVrMzZyQlZLa1YzU2FlWXRKcnZEVlRiZmJ1bG96a09abnlfTWl5blYxcGo5ZU5HOEJyaUVHdEVRaUJOTEpLMjFZSTVraVF2MENHNG1LSUJMUC04cnVaZUpyU1p2cGdSMndvZ3p4a1dSY1JQUV…

Google News Mon, 20 Jul 2026

VOLITIONRX LTD SEC Filing (Jul 20, 2026) | VNRX EFFECT - Stock Titan

<a href="https://news.google.com/rss/articles/CBMimgFBVV95cUxOQWN6bWhvVXJNMHR2UjFEUzdKNnoxajBJVjQ0em94Y0Vnc3g2WWlGOVNraVdBWnBVRkplWjc0ZWxnS1JSOFVCbE93UnpMNGJDMHhzaExUeGZhcDFHQldkaTVfNTZQWE93enpfeGVjUzJoT2hDOGNxTzI4OUJmcVctckdMTTN3NmNtTl9PWj…

VNRX — Frequently Asked Questions

What is the current share price of VNRX?

As of 2026-08-05 17:25 PDT, VNRX trades at $0.80 on NASDAQ/NYSE. Its 52-week range is $0.72 to $13.80.

What is the market capitalisation of VNRX?

VNRX has a market capitalisation of $5.03M on NASDAQ/NYSE.

What is the P/E ratio of VNRX?

VNRX trades at a trailing price-to-earnings (P/E) ratio of -0.18. Its price-to-book (P/B) ratio is -0.15.

What is the return on equity (ROE) of VNRX?

VNRX has a return on equity (ROE) of 68.20%.

Is VNRX a good stock to buy?

This page provides a data-driven analysis of VNRX, including valuation ratios, profitability, growth trends, auto-generated pros and cons, peer comparison and AI exposure. Review these fundamentals alongside your own research and risk tolerance. This is informational content, not investment advice.

Explore More

🔍 All Stock Screens 📈 Technical Screens 💰 Fundamental Screens 🔄 Swing Trading Setups 📐 Chart Patterns 📅 Earnings Calendar 📋 All USA Stocks
⚙Ad space